Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
ACS Appl Bio Mater ; 7(8): 5037-5056, 2024 Aug 19.
Artículo en Inglés | MEDLINE | ID: mdl-38787767

RESUMEN

The oral and nasal cavities serve as critical gateways for infectious pathogens, with microorganisms primarily gaining entry through these routes. Our first line of defense against these invaders is the mucosal membrane, a protective barrier that shields the body's internal systems from infection while also contributing to vital functions like air and nutrient intake. One of the key features of this mucosal barrier is its ability to protect the physiological system from pathogens. Additionally, mucosal tolerance plays a crucial role in maintaining homeostasis by regulating the pH and water balance within the body. Recognizing the importance of the mucosal barrier, researchers have developed various mucosal formulations to enhance the immune response. Mucosal vaccines, for example, deliver antigens directly to mucosal tissues, triggering local immune stimulation and ultimately inducing systemic immunity. Studies have shown that lipid-based formulations such as liposomes and virosomes can effectively elicit both local and systemic immune responses. Furthermore, mucoadhesive polymeric particles, with their prolonged delivery to target sites, have demonstrated an enhanced immune response. This Review delves into the critical role of material selection and delivery approaches in optimizing mucosal immunity.


Asunto(s)
Materiales Biocompatibles , Inmunidad Mucosa , Inmunidad Mucosa/efectos de los fármacos , Humanos , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Vacunas/inmunología , Vacunas/administración & dosificación , Membrana Mucosa/inmunología , Animales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA